These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 17967781

  • 1. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S, Aihara K, Ikeda Y, Sumitomo Y, Yoshida S, Ise T, Iwase T, Ishikawa K, Azuma H, Akaike M, Matsumoto T.
    Circ Res; 2008 Jan 04; 102(1):68-76. PubMed ID: 17967781
    [Abstract] [Full Text] [Related]

  • 2. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
    Yagi S, Akaike M, Aihara K, Ishikawa K, Iwase T, Ikeda Y, Soeki T, Yoshida S, Sumitomo-Ueda Y, Matsumoto T, Sata M.
    Hypertension; 2010 Apr 04; 55(4):918-23. PubMed ID: 20194307
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J, Basu R, Guo D, Chow FL, Byrns S, Schuster M, Loibner H, Wang XH, Penninger JM, Kassiri Z, Oudit GY.
    Circulation; 2010 Aug 17; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD, Albornoz F, Griffin JP, Crandall DL, Elokdah H, Fogo AB, Vaughan DE, Brown NJ.
    Arterioscler Thromb Vasc Biol; 2005 Feb 17; 25(2):365-71. PubMed ID: 15576638
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pitavastatin improves cardiac function and survival in association with suppression of the myocardial endothelin system in a rat model of hypertensive heart failure.
    Saka M, Obata K, Ichihara S, Cheng XW, Kimata H, Nishizawa T, Noda A, Izawa H, Nagata K, Murohara T, Yokota M.
    J Cardiovasc Pharmacol; 2006 Jun 17; 47(6):770-9. PubMed ID: 16810078
    [Abstract] [Full Text] [Related]

  • 8. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Niu P, Shindo T, Iwata H, Iimuro S, Takeda N, Zhang Y, Ebihara A, Suematsu Y, Kangawa K, Hirata Y, Nagai R.
    Circulation; 2004 Apr 13; 109(14):1789-94. PubMed ID: 14967720
    [Abstract] [Full Text] [Related]

  • 9. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
    Kaji H, Naito J, Inoue Y, Sowa H, Sugimoto T, Chihara K.
    Horm Metab Res; 2008 Nov 13; 40(11):746-51. PubMed ID: 18622892
    [Abstract] [Full Text] [Related]

  • 10. Targeting the calpain/calpastatin system as a new strategy to prevent cardiovascular remodeling in angiotensin II-induced hypertension.
    Letavernier E, Perez J, Bellocq A, Mesnard L, de Castro Keller A, Haymann JP, Baud L.
    Circ Res; 2008 Mar 28; 102(6):720-8. PubMed ID: 18258859
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL, Yin H, Huang J.
    Cardiovasc Pathol; 2007 Mar 28; 16(4):221-30. PubMed ID: 17637430
    [Abstract] [Full Text] [Related]

  • 12. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N, Dong P, Huang Q, Jin W, Zhang J, Dai Q, Liu S.
    Clin Exp Pharmacol Physiol; 2009 Mar 28; 36(3):262-6. PubMed ID: 18785976
    [Abstract] [Full Text] [Related]

  • 13. TGF-beta1 and angiotensin networking in cardiac remodeling.
    Rosenkranz S.
    Cardiovasc Res; 2004 Aug 15; 63(3):423-32. PubMed ID: 15276467
    [Abstract] [Full Text] [Related]

  • 14. Rosuvastatin attenuates Ang II--mediated cardiomyocyte hypertrophy via inhibition of LOX-1.
    Kang BY, Mehta JL.
    J Cardiovasc Pharmacol Ther; 2009 Dec 15; 14(4):283-91. PubMed ID: 19724024
    [Abstract] [Full Text] [Related]

  • 15. Antifibrotic effect of adrenomedullin on coronary adventitia in angiotensin II-induced hypertensive rats.
    Tsuruda T, Kato J, Hatakeyama K, Masuyama H, Cao YN, Imamura T, Kitamura K, Asada Y, Eto T.
    Cardiovasc Res; 2005 Mar 01; 65(4):921-9. PubMed ID: 15721873
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Androgen-androgen receptor system protects against angiotensin II-induced vascular remodeling.
    Ikeda Y, Aihara K, Yoshida S, Sato T, Yagi S, Iwase T, Sumitomo Y, Ise T, Ishikawa K, Azuma H, Akaike M, Kato S, Matsumoto T.
    Endocrinology; 2009 Jun 01; 150(6):2857-64. PubMed ID: 19196803
    [Abstract] [Full Text] [Related]

  • 19. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway.
    Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M.
    Life Sci; 2004 Jul 30; 75(11):1333-41. PubMed ID: 15234191
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D, Sairam MR, Neves MF, Schiffrin EL, Touyz RM.
    J Hypertens; 2006 Jul 30; 24(7):1365-73. PubMed ID: 16794486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.